CTIC Annual Total Long Term Liabilities
$62.37 M
+$60.35 M+2993.65%
31 December 2022
Summary:
As of February 5, 2025, CTIC annual total long term liabilities is $62.37 million, with the most recent change of +$60.35 million (+2993.65%) on December 31, 2022. During the last 3 years, it has risen by +$52.51 million (+532.41%).CTIC Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTIC Quarterly Long Term Liabilities
$69.39 M
+$7.03 M+11.26%
31 March 2023
Summary:
As of February 5, 2025, CTIC quarterly total long term liabilities is $69.39 million, with the most recent change of +$7.03 million (+11.26%) on March 31, 2023. Over the past year, it has increased by +$8.97 million (+14.85%).CTIC Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTIC Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2993.7% | +14.8% |
| 3 y3 years | +532.4% | +819.5% |
| 5 y5 years | +219.2% | +276.4% |
CTIC Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -73.1% | -70.1% |
CTI BioPharma Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $69.39 M(+11.3%) |
| Dec 2022 | $62.37 M(+2993.7%) | $62.37 M(-43.6%) |
| Sept 2022 | - | $110.53 M(+0.5%) |
| June 2022 | - | $110.02 M(+82.1%) |
| Mar 2022 | - | $60.42 M(+2897.0%) |
| Dec 2021 | $2.02 M(+71.7%) | $2.02 M(>+9900.0%) |
| Sept 2021 | - | $0.00(0.0%) |
| June 2021 | - | $0.00(-100.0%) |
| Mar 2021 | - | $577.00 K(-50.9%) |
| Dec 2020 | $1.17 M(-88.1%) | $1.17 M(-33.0%) |
| Sept 2020 | - | $1.75 M(-69.8%) |
| June 2020 | - | $5.80 M(-23.1%) |
| Mar 2020 | - | $7.55 M(-23.5%) |
| Dec 2019 | $9.86 M(-28.7%) | $9.86 M(+120.5%) |
| Sept 2019 | - | $4.47 M(-66.3%) |
| June 2019 | - | $13.28 M(-11.3%) |
| Mar 2019 | - | $14.96 M(+8.1%) |
| Dec 2018 | $13.84 M(-29.2%) | $13.84 M(-9.4%) |
| Sept 2018 | - | $15.27 M(-8.6%) |
| June 2018 | - | $16.70 M(-9.4%) |
| Mar 2018 | - | $18.43 M(-5.6%) |
| Dec 2017 | $19.54 M(+26.5%) | $19.54 M(+79.0%) |
| Sept 2017 | - | $10.92 M(-0.3%) |
| June 2017 | - | $10.95 M(-16.8%) |
| Mar 2017 | - | $13.16 M(-14.8%) |
| Dec 2016 | $15.44 M(-36.7%) | $15.44 M(-12.6%) |
| Sept 2016 | - | $17.67 M(-12.2%) |
| June 2016 | - | $20.12 M(-9.9%) |
| Mar 2016 | - | $22.34 M(-8.3%) |
| Dec 2015 | $24.38 M(+39.5%) | $24.38 M(-55.0%) |
| Sept 2015 | - | $54.16 M(-3.1%) |
| June 2015 | - | $55.89 M(+311.9%) |
| Mar 2015 | - | $13.57 M(-22.3%) |
| Dec 2014 | $17.47 M(-43.5%) | $17.47 M(-26.4%) |
| Sept 2014 | - | $23.74 M(-4.2%) |
| June 2014 | - | $24.78 M(-22.4%) |
| Mar 2014 | - | $31.95 M(+3.4%) |
| Dec 2013 | $30.90 M(+70.7%) | $30.90 M(+17.4%) |
| Sept 2013 | - | $26.32 M(-2.5%) |
| June 2013 | - | $27.01 M(-1.7%) |
| Mar 2013 | - | $27.46 M(+51.7%) |
| Dec 2012 | $18.10 M(+10.1%) | $18.10 M(-5.9%) |
| Sept 2012 | - | $19.23 M(-3.4%) |
| June 2012 | - | $19.91 M(+17.2%) |
| Mar 2012 | - | $16.98 M(+3.3%) |
| Dec 2011 | $16.45 M(-6.9%) | $16.45 M(-0.6%) |
| Sept 2011 | - | $16.55 M(-2.1%) |
| June 2011 | - | $16.90 M(-3.3%) |
| Mar 2011 | - | $17.47 M(-1.1%) |
| Dec 2010 | $17.67 M(-27.9%) | $17.67 M(-33.2%) |
| Sept 2010 | - | $26.46 M(+4.5%) |
| June 2010 | - | $25.31 M(+4.6%) |
| Mar 2010 | - | $24.21 M(-1.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2009 | $24.50 M(-84.1%) | $24.50 M(-5.9%) |
| Sept 2009 | - | $26.05 M(-63.3%) |
| June 2009 | - | $70.95 M(-41.8%) |
| Mar 2009 | - | $121.97 M(-20.8%) |
| Dec 2008 | $154.00 M(+20.4%) | $154.00 M(-17.8%) |
| Sept 2008 | - | $187.41 M(+3.6%) |
| June 2008 | - | $180.82 M(+24.8%) |
| Mar 2008 | - | $144.88 M(+13.3%) |
| Dec 2007 | $127.86 M(-24.4%) | $127.86 M(+4.9%) |
| Sept 2007 | - | $121.87 M(+5.3%) |
| June 2007 | - | $115.78 M(-30.9%) |
| Mar 2007 | - | $167.47 M(-0.9%) |
| Dec 2006 | $169.05 M(-27.1%) | $169.05 M(-2.9%) |
| Sept 2006 | - | $174.15 M(-4.6%) |
| June 2006 | - | $182.61 M(+6.0%) |
| Mar 2006 | - | $172.34 M(-25.6%) |
| Dec 2005 | $231.75 M(+4.6%) | $231.75 M(+17.2%) |
| Sept 2005 | - | $197.69 M(+1.1%) |
| June 2005 | - | $195.54 M(-12.0%) |
| Mar 2005 | - | $222.20 M(+0.3%) |
| Dec 2004 | $221.59 M(+13.6%) | $221.59 M(+12.8%) |
| Sept 2004 | - | $196.38 M(-0.0%) |
| June 2004 | - | $196.40 M(-0.4%) |
| Mar 2004 | - | $197.27 M(+1.1%) |
| Dec 2003 | $195.11 M(+60.2%) | $195.11 M(+0.2%) |
| Sept 2003 | - | $194.65 M(-0.5%) |
| June 2003 | - | $195.56 M(+61.6%) |
| Mar 2003 | - | $121.02 M(-0.6%) |
| Dec 2002 | $121.80 M(-31.9%) | $121.80 M(-32.3%) |
| Sept 2002 | - | $180.02 M(-0.2%) |
| June 2002 | - | $180.41 M(+1.0%) |
| Mar 2002 | - | $178.62 M(-0.2%) |
| Dec 2001 | $178.89 M(>+9900.0%) | $178.89 M(+2.1%) |
| Sept 2001 | - | $175.15 M(+16.3%) |
| June 2001 | - | $150.58 M(>+9900.0%) |
| Mar 2001 | - | $823.60 K(-22.2%) |
| Dec 2000 | $1.06 M(-59.3%) | $1.06 M(-31.8%) |
| Sept 2000 | - | $1.55 M(-87.3%) |
| June 2000 | - | $12.24 M(-2.7%) |
| Mar 2000 | - | $12.57 M(+383.6%) |
| Dec 1999 | $2.60 M(-33.3%) | $2.60 M(-13.3%) |
| Sept 1999 | - | $3.00 M(-9.1%) |
| June 1999 | - | $3.30 M(-5.7%) |
| Mar 1999 | - | $3.50 M(-10.3%) |
| Dec 1998 | $3.90 M(+85.7%) | $3.90 M(+11.4%) |
| Sept 1998 | - | $3.50 M(+94.4%) |
| June 1998 | - | $1.80 M(-10.0%) |
| Mar 1998 | - | $2.00 M(-4.8%) |
| Dec 1997 | $2.10 M(0.0%) | $2.10 M(+110.0%) |
| Sept 1997 | - | $1.00 M(-28.6%) |
| June 1997 | - | $1.40 M(-17.6%) |
| Mar 1997 | - | $1.70 M |
| Dec 1996 | $2.10 M | - |
FAQ
- What is CTI BioPharma annual total long term liabilities?
- What is the all time high annual total long term liabilities for CTI BioPharma?
- What is CTI BioPharma annual total long term liabilities year-on-year change?
- What is CTI BioPharma quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for CTI BioPharma?
- What is CTI BioPharma quarterly long term liabilities year-on-year change?
What is CTI BioPharma annual total long term liabilities?
The current annual total long term liabilities of CTIC is $62.37 M
What is the all time high annual total long term liabilities for CTI BioPharma?
CTI BioPharma all-time high annual total long term liabilities is $231.75 M
What is CTI BioPharma annual total long term liabilities year-on-year change?
Over the past year, CTIC annual total long term liabilities has changed by +$60.35 M (+2993.65%)
What is CTI BioPharma quarterly total long term liabilities?
The current quarterly long term liabilities of CTIC is $69.39 M
What is the all time high quarterly long term liabilities for CTI BioPharma?
CTI BioPharma all-time high quarterly total long term liabilities is $231.75 M
What is CTI BioPharma quarterly long term liabilities year-on-year change?
Over the past year, CTIC quarterly total long term liabilities has changed by +$8.97 M (+14.85%)